In a pioneering collaboration with AbbVie, Northwestern researchers have discovered a new way to potentially treat cancer by ...
We have selected the protein group of RING type ubiquitin E3 ligases to assign them in plant developmental stages and organs by gene expression profiles, by high throughput phenotyping of ...
Hosted on MSN6mon
Developing new methods for targeted protein degradationInvestigators found that an E3 ligase FBXO22 could effectively mediate ... will continue to explore the use of TPD in different types of cancer. "We can use this method to continue to discover ...
Professor Zoran Rankovic’s group is developing PROTACs, Molecular Glue Degraders, and E3 ubiquitin ligase chemical probes to study cancer biology and develop novel cancer drugs. Our group's research ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results